Skip to ContentSkip to Navigation
About us Latest news News News articles

Zijlstra to extend funding for top research schools Zernike Institute for Advanced Materials and NOVA

06 July 2011

State Secretary Halbe Zijlstra is planning to extend the funding for the Zernike Institute for Advanced Materials, according to the Strategic Agenda he submitted to the Dutch House of Representatives last Friday. Funding for the top research school in astronomy NOVA is also set to be prolonged.

NOVA and the Zernike Institute for Advanced Materials both received the predicate ‘exemplary’ after an evaluation by NWO last year, as they had both proven that they are among the very best in their field.

At the Zernike Institute for Advanced Materials, physicists, chemists and biologists collaborate on interdisciplinary research into new materials that will shape the future. Nanoscience has an extremely important role to play in this regard.

The world-class nature of the research taking place at the Zernike Institute for Advanced Materials was confirmed last year by a ranking of materials research institutes published by the British education journal Times Higher Education. The Zernike Institute for Advanced Materials came in ninth place, ahead of prestigious universities such as Princeton, Stanford and Cambridge.

Last modified:13 March 2020 01.57 a.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 28 April 2025

    Engineering Smart Decisions for a Dynamic World

    Dynamical systems, i.e. mathematical models that describe how things evolve over time, are at the heart of much of the modern world. The real challenge, however, lies in shaping the systems’ behaviour to achieve a specific goal.

  • 25 April 2025

    Leading microbiologist Arnold Driessen honoured

    On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...

  • 24 April 2025

    Highlighted papers April 2025

    The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.